HPS Pharmacies wish to give notice that Pfizer Australia are anticipating a supply interruption for aminophylline ampoules as follows:
DBL™ Aminophylline Injection
Pfizer estimates that supplies will be impacted from late April 2020. An update will be issued when an expected date of return is available. This supply issue is due to increased demand; there are no safety concerns with this product.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer Australia on 1800 675 229 or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates